Bottom line
What is IMYCX's expense ratio?
IMYCX's expense ratio is 1.77%, or about $177 a year on every $10,000 invested. That is more expensive than 97% of high-yield bond funds we track (median 0.74%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Jul 29, 2026
IMYCX fee table
| Net expense ratio | 1.77% |
|---|---|
| Gross expense ratio | 1.86% |
| Management fee | 0.61% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.25% |
| Fee waiver / reimbursement | -0.09% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Jul 29, 2026
What IMYCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IMYCX | $280 | $576 | $997 | $2,172 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.77% expense ratio costs roughly $91,700 in lost growth, versus about $41,900 for the median high-yield bond fund (0.74%).